During the selection process, volunteers undergo a complex clinical and laboratory examination, including a medical check-up, an electrocardiogram, blood and urine tests, etc. The testing is free of charge.
Read more about the screening process
The patient takes part in a clinical trial only based on VOLUNTARY informed consent. The patient is provided with all information related to the goals, methods, organization of the trial, the possible benefits and potential risks associated with the research. By signing the Informed Consent form, patients confirm their voluntary consent and acknowledge that they have read, understand, and agree to the policies. The primary investigator’s signature on the form certifies the provision of all the necessary information on the study to the patient. The patient can quit the study at any time without explanation.
Every clinical trial patient is under close medical observation by highly qualified specialists. Patients also have access to the most advanced medicines and technologies.
Under the law and regulations, all data provided is subjected to masking to maintain the confidentiality of patients who participated in the trial.
Read more about informed consent
The schedule of visits is developed individually for each clinical trial and is recorded in the protocol. It is necessary to see a doctor several times a week in some cases, while in others, it can be no more than once a month. Therefore, it is vital to get acquainted with the protocol and informed consent. To do this, you can take them home for a while and then make a decision.
Some studies require spending several days (nights) in the clinic. This fact should also be taken into account.
The participants always have the right to withdraw their consent at any time.
This is very painful for all of us: for drug manufacturers – because they need to spend the drug again for a new person, for the hospital – because they need to recruit a new patient, the doctor has to perform all control stages. If patients withdraw reasonably: the doctor sees that the patient has developed an unwanted reaction to the drug; he is also excluded from the study.